Development of Synthetic Lethality Anticancer Therapeutics is a research paper published in Journal of Medicinal Chemistry (2014). On theSindex it has a DataRank of 0.639. It has been cited 70 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.639
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Cancer Institute
Grant: R01CA124951
National Institutes of Health
Grant: 5R01CA124951-02
Novel CTD inhibitors with synthetic lethality to oncogenic Ras for cancer therapy
Fields of Study
MeSH Terms
Sustainable Development Goals
BindingDB Entry 50045098: Development of synthetic lethality anticancer therapeutics.